Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share (ITOS).
- Disclosed ownership: 100%.
- Date of event: 29 Aug 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 100% ownership in ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share (ITOS) on 29 Aug 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 100% | 10,000 | 0 | 10,000 | /s/ Kevin Tang | Manager | 0001232621 |
| KEVIN TANG | 100% | 10,000 | 0 | 10,000 | /s/ Kevin Tang | Self | 0001178579 |
| TANG CAPITAL PARTNERS, LP | 100% | 10,000 | 0 | 10,000 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0001191935 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0002064011 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | 0002036763 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | 0002036770 |
| CONCENTRA BIOSCIENCES, LLC | 100% | 10,000 | 0 | 10,000 | /s/ Kevin Tang | Chief Executive Officer | 0001970065 |
| CONCENTRA MERGER SUB VIII, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |